ACROBiosystems Efforts and Collaborations in Cancer Immunotherapy
Speaking at The Landscape of Cancer Research 2022, Nicholas Abuid, PhD from ACROBiosystems, presented his talk on providing high purity, customizable, and bioactive reagents to support research and translation in cancer immune therapy. Their catalogue ranges in targets for various diseases.
Re-Convolving the Compositional Landscape of Primary and Recurrent Glioblastoma Reveals Prognostic and Targetable Tissue States
Speaking at The Landscape of Cancer Research 2022, Osama Al Dalahmah, PhD from Colombia University, presented his talk on paving the way to new mechanistic and therapeutic discoveries in glioblastoma.
Analysis of Non-Blood Body Fluids
The best fluids for mining disease biomarkers are closest to the site of pathology. For example, rather than serum or plasma, urine is a better fluid to in patients with urinary tract diseases, and stool may be a preferred material to examine in a subject with gastrointestinal disease.
The Landscape of Cancer Research 2022
Returning for a second year, this online event will provide researchers with a unique opportunity to hear about the advances taking place within cancer research. We will bring together a broad cross-section of experts to share their work in areas such as omics, immunology, drug discovery and cell science.
Introducing Cancer Genomics With Long Reads
The last twenty years have experienced extensive growth in the sequencing of cancer genomes, leading to a dramatically increased understanding of the role of genetic and epigenetic mutations in cancer.
Scaling Non-Viral Cell Therapy Approaches for Solid Tumor Treatments
In this webinar, speakers from PACT Pharma Inc. and Thermo Fisher Scientific discuss how modular instrumentation platforms can enable automation and standardization of the end-to-end manufacturing workflow, from cell isolation and activation to genetic modification and expansion.